A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Clinical trial NCT05652335 · RECRUITING
Trial details
- NCT number
- NCT05652335
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-22
- Primary completion
- 2027-04-19
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.